Aduhelm Controversy: Why the FDA Approval Divided the Medical World

The FDA's approval of Aduhelm on June 7, 2021 divided the medical world because the agency overrode its own advisory committee — which had voted 10 to 1...

The FDA's approval of Aduhelm on June 7, 2021 divided the medical world because the agency overrode its own advisory committee — which had voted 10 to 1...

When biologics stop working for autoimmune disease, patients face a frustrating but surprisingly common reality: an estimated 30 to 40 percent of people...

The FDA approved Gazyva (obinutuzumab) on October 20, 2025, for adult patients with active lupus nephritis — making it only the third drug ever greenlit...

Nerve pain is so difficult to treat because it does not behave like ordinary pain. While a broken bone or a pulled muscle sends a clear, proportional...

Bimekizumab, sold under the brand name Bimzelx, is the psoriasis drug that is rewriting what doctors and patients expect from treatment.

Minocycline foam, sold under the brand name Amzeeq, is a topical formulation of the tetracycline-class antibiotic minocycline that has gained significant...

The foods most likely to trigger your migraines are ones you probably consume every day: chocolate, cheese, coffee, wine, and tea.

The migraine medications most likely to cause permanent-feeling rebound headaches are combination analgesics containing opioids or barbiturates — drugs...

The sedating antipsychotic at the center of this controversy is quetiapine, sold under the brand name Seroquel.

ADHD medication works for some adults and not others primarily because of individual differences in brain chemistry — specifically, the ratio of dopamine...
HelpDementia.com
Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance
© 2026 HelpDementia.com. All rights reserved.
Educational information only. It is not medical advice and does not replace care from a qualified clinician.